Literature DB >> 3909406

Acupuncture for rheumatoid arthritis: an analysis of the literature.

D Bhatt-Sanders.   

Abstract

Despite the claims that acupuncture is beneficial in the treatment of stages I and II rheumatoid arthritis (RA), few satisfactory double-blind controlled studies exist. A review of the world literature showed eight studies examining the efficacy of acupuncture in RA. Five studies claim that acupuncture treatments give significant pain relief. Two studies claim that there is no significant difference between real and placebo acupuncture in RA. One study claims that acupuncture has antiinflammatory effects. Analysis of problems related to study design demonstrates that methodological flaws invalidate in varying degrees the broad spectrum of conclusions. The need for a more effective therapeutic armamentarium in the treatment of RA makes it imperative that satisfactory trials of acupuncture for RA be conducted in the future.

Entities:  

Mesh:

Year:  1985        PMID: 3909406     DOI: 10.1016/0049-0172(85)90041-1

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  5 in total

1.  The exodus of the non-rational from orthodox medicine.

Authors:  A Pletscher
Journal:  Experientia       Date:  1994-04-15

Review 2.  The optimum management of arthropathies.

Authors:  C S Wolfe; G R Hughes
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

Review 3.  Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis.

Authors:  L Casimiro; L Barnsley; L Brosseau; S Milne; V A Robinson; P Tugwell; G Wells
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

Review 4.  Clinical Efficacy of Acupuncture on Rheumatoid Arthritis and Associated Mechanisms: A Systemic Review.

Authors:  Pei-Chi Chou; Heng-Yi Chu
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-12       Impact factor: 2.629

5.  Acupuncture in the treatment of rheumatoid arthritis: a double-blind controlled pilot study.

Authors:  Lai-Shan Tam; Ping-Chung Leung; Tena K Li; Lang Zhang; Edmund K Li
Journal:  BMC Complement Altern Med       Date:  2007-11-03       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.